Latest filing published 02 Mar 2022 for Akebia Therapeutics, Inc., €12k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Dell Faulkingham: trading record in brief
Dell Faulkingham appears in our data through filings on Akebia Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 11 filings, for trades running from 31 May 2019 to 1 March 2022.
No open-market purchase appears, only 6 sales worth €114k. Outside the open market, there are 5 share grants. So far in 2022, the count stands at no purchases and 3 sales.
On 2 March 2022 came the latest disclosure, an open-market sale for €11k in Akebia Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Dell Faulkingham
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,479 shares@ US$2.1548100.0% of flowCommon StockSEC:0001562180-22-002162:0
1 of 1 declaration
